Tackling drug resistance: how our commensal bacteria can hinder or help
Response to therapeutics can differ widely from patient to patient, with some gaining highly significant survival benefits from a therapy that in others elicits no response at all. Patients who…
Evolution of the doctor-patient relationship: from ancient times to the personalised medicine era
The nature of the doctor–patient relationship has gone through various phases in history, based on the changing role of the physician in the community, as well as progress in medicine…
Informal carers play a key role in cancer care: they need and deserve more support
What is it worth to patients to have someone they can rely on to provide emotional support and talk things through, help them get to and from appointments, remind them…
NEWS
Academic oncology: women’s careers at high risk for continued inequality
More than half of women in oncology practice believe their gender adversely affects their prospects for job promotion, especially in academia. The cross-sectional survey, published in JAMA Netw Open (December…
SPCC Strategic Plan 2020-2022
SPCC wants to confirm and broaden its activity as an internationally recognised and highly respected provider of independent, evidence-based medical education in the cancer field and to increase knowledge in…
Stakeholders Unite: Time to Charge Up Pancreatic Cancer Care Across Europe!
The European Cancer Organisation, in strong alliance with a collaboration of 22 healthcare professional and patient organisations, is today marking the publication the “Essential Requirements for Quality Cancer Care: Pancreatic Cancer” as…
Real-Life Stories of HPV-Related Cancers Underline Urgent Need for Access to Vaccination and Screening
Human papillomavirus (HPV) vaccinations have achieved a huge reduction in cancer incidence. Recently-published research from the UK found that vaccination has almost eliminated cervical cancer in women in the vaccinated…
Catching All Cancers Earlier: A Critical Principle for New EU Recommendations
This morning, the European Cancer Organisation has published a fresh stakeholder consensus statement that expresses advice to the EU on how to ensure new recommendations to Member States on detecting…
CONTENTS
ARTICLES
Lung cancer screening: 2022 could be a turning point for Europe
If cancer screening policies were driven purely by mortality rates and curability, then lung cancer would long have topped the priority list for population screening programmes. Accounting for almost one…
